胃癌合并2型糖尿病病人术后糖尿病改善相关因素分析

发布时间：2018-02-04 14:13

  本文关键词： 胃癌 型糖尿病 手术治疗　出处：《中国实用外科杂志》2017年02期 　论文类型：期刊论文

【摘要】：目的探讨影响胃癌合并2型糖尿病(T2DM)病人术后糖尿病改善的相关因素。方法回顾性分析2013年1月至2016年7月第二军医大学附属长海医院162例胃癌合并T2DM病人临床及随访资料,包括性别、年龄、糖尿病病程、随访术后血糖变化及用药情况,肿瘤大小、分型、分期、浸润深度、淋巴转移情况,以及胃癌根治手术不同手术方式治疗(Bypass-:BillrothⅠ式吻合、近端胃切除;Bypass+:全胃或远端胃切除+Roux-en-Y吻合),采用CMH及秩和检验进行单因素分析,并对相关因素进行logistic回归分析。结果胃癌合并T2DM病人术后效果与病人年龄、肿瘤大小、手术方式及病程长短存在明显相关性。而与病人性别、术后血糖变化及用药情况、肿瘤分型、分期、浸润深度、淋巴转移情况指数无明显相关性。结论对于胃癌合并T2DM病人,Bypass+有助于改善胃癌术后病人血糖,特别是T2DM病程较短、年龄较小、肿瘤较小病人,以此提高术后短期内糖尿病改善。
[Abstract]:Objective to investigate the effect of T2DM on gastric cancer complicated with type 2 diabetes mellitus (T2DM). Methods the clinical and follow-up data of 162 patients with gastric cancer complicated with T2DM in Changhai Hospital affiliated to the second military Medical University from January 2013 to July 2016 were retrospectively analyzed. . These included sex, age, course of diabetes, changes in blood glucose and medication, tumor size, classification, staging, depth of invasion, lymphatic metastasis after follow-up. And different surgical methods of radical gastrectomy were used to treat Bypass-proportion Billroth 鈪，

本文编号：1490409